Loading...
XSHG
600750
Market cap2.07bUSD
Dec 05, Last price  
23.01CNY
1D
-0.78%
1Q
5.26%
Jan 2017
56.78%
Name

Jiang Zhong Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600750 chart
P/E
18.54
P/S
3.29
EPS
1.24
Div Yield, %
5.22%
Shrs. gr., 5y
0.02%
Rev. gr., 5y
12.61%
Revenues
4.44b
+1.03%
979,471,3431,181,073,4551,168,589,3041,457,643,3111,890,024,3312,563,606,1992,647,303,9293,191,844,6942,777,861,3432,834,124,3392,597,351,4341,561,863,0811,746,642,5281,755,229,0222,449,404,4422,441,451,7892,873,974,4623,811,641,5104,390,101,9784,435,450,590
Net income
788m
+11.28%
53,629,43976,323,26496,599,416130,618,543201,095,148261,203,025227,818,447225,336,056172,255,405264,847,938367,012,144379,763,770417,796,582470,248,224463,596,527473,739,388505,687,248598,241,179708,291,520788,192,557
CFO
786m
-24.10%
198,445,96755,242,615153,631,577268,873,134378,316,022222,292,622168,295,685226,380,995111,918,811356,804,768510,778,275698,045,543124,928,619486,245,960641,177,784752,501,253917,037,6601,015,989,4161,035,899,563786,252,548
Dividend
Oct 10, 20240.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of traditional Chinese medicine and health foods. The company offers OTC class products for gastrointestinal digestion, upper respiratory tract, and tonics; protein nutrition, tonics, health regimen, probiotics, daily protection, beauty, bone health, and plant liver protection health products; and prescription products. It sells its products under the Jiangzhong and Jianweixiaoshi brands. Jiang Zhong Pharmaceutical Co.,Ltd is based in Nanchang, China.
IPO date
Sep 23, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT